How about all the days when the market was up?
Did you say that INO was only up because the markets were up?
I don't recall seeing that post.
Want an explanation? The pos is way overvalued. $700M for a Company that hasn't been able to complete one P3 trial in 35 years? $700M for failure? Wanna buy some $100 tulip bulbs from me?
Do you know what Microsoft's IPO valuation was? MSFT had $hundreds of millions of sales and profits. it was a fraction of INO's current bloated market cap.
What did you think would happen after the reverse split?
The pps dropped from $50 to 50 cents after the first reverse split.
Buy stocks with forward splits.
Run like heck from stocks with reverse splits.
Correction: Braeburn expects trial completion in mid 2015, that means late 2015 at the earliest.
And the launch would be in 2017 if another CRL is not issued.
They are zipping along .... just another 170 patients more to go.
So the trial starts in November and completes in April,
The 2 months to analyze the data and a month to prepare the resubmission.
So the PDUFA date should be some time in early 2016.
The patent expires April 2024.
There will be about 7 to 8 years of royalties.
Some optimistic numbers: $20M + $40M + $60M + $90M + $120M + $150M + $200M =
$680M sales X 20% royalty = $130M in royalties.
Less operating expenses of $8M annually for 7 years = ($56M)
So, TTNP will have about $75M cash in 2024.
$75M / 125M shares = .60 in 2024
What's all the hub about?
TTNP is much ado about nothing.
Yawn ..... are the notes of some hired hack supposed to be of importance to anyone?
When saps buy a dung stock and it drops, they blame it on manipulation, not their own stupidity.
Ever consider that the run up to the .90s was manipulation so that the hedgies could sell short before the dilutive financing was announced?
An overdiluted penny stock is not a bargain.
It only runs up in the pump phase of a Pump & Dump and then comes crashing down in the dump phase.
Buy a quality stock run by competent management, not by political science majors.
That would explain why institutional holdings are a small fraction of 1%.
This is just Punit and the hedge funds reaming your derriere.
Buying other companies failed drugs is a losing strategy.
They are very happy. They shorted the stock in the .80s and covered with the .71 shares.
Idiots who bought the shares that the hedgies shorted in the .80s and mid to high .70s are not happy now.
There is no good news. Do you want him to create news out of thin air?
You can't turn a sow's ear into a silk purse.
Ahn at GALE hired the DreamTeam to pump the stock while insiders dumped.
The Company is now under SEC investigation and subject to derivative lawsuits.
An underwriter is an investment banking firm. Punit goes hat in hand to an underwriter. They agree on the amount of the offering, the percentage discount and the amount of freebie warrants that will be issued. The underwriter then calls his favorite hedgies and offers them a piece of the underwriting. Discounted offerings are prized more than IPOs. It's guaranteed risk free profits for the hedgies to dress up their annual returns. They probably never even heard of ONCS, but taking shares at .71 that are trading at .85 is a no brainer. The hedgies immediately start selling short their allotment, whether it's directly, through the underwriter or through the MM. A lot of the short sales are completed before the financing is even made public. Punit than thanks the hedgies for having to screw shareholders by stuffing freebie warrants in their pockets.
How is it illegal? Read the prospectus. A snippet was posted above.
The end of the month short report will not show short positions taken from June 2, 3, 4,.... and covered with the June 21 discounted share offering. The short positions taken on June 22, 23 24.... which were closed out with the shares from the discounted share offering will not show up in the July 1 short report.
Also, the MMs are not required to disclose their short positions. So a hedgie can work through the MM to establish a short position that you would not know about.
The proof is in the pudding. ONCS sold about 200M shares to "institutions" the past 3 years, yet institutional holdings are nonexistent. Explain that.
I think the purpose of the post was to counter the pumpers who hype that a big money institution invested in ONCS and it's smart money, so you too should invest too. Nothing could be further from the truth. Some 200M shares were sold in the past 3 years, yet the institutional holdings are nonexistent. It should be obvious what is transpiring. atduvall posted that the buyers of the offering could not sell short and quoted an SEC regulation prohibiting it. When bonehead proved him wrong, he removed his post.
There are many ways to raise funds: partnerships, grants, sale of restricted shares, loans, sale of stock to a big pharma or a long term investor. The Punit method batters shareholders as it transfers money from their pockets into the pockets of the hedgies.
Dumbo, ONCS has 57M shares outstanding 3 years ago, now it's 250M.
Biotechs all state the same reasons for the dilution - R & D, trials, general corporate purposes (which encompasses: management compensation packages, incentive plans, golden parachutes and retirement packages, travel reimbursements and sometimes private planes...)
When insiders sell shares the standard reason given is to diversify their holdings, they won't tell you that it is because the pps is overpriced.
Repeating the standard reasons provided for dilution or insider sales shows hoe gullible you are.
Evaluate the amount of dilution and the results that it produced.
Inovio, a company that the Dhillon boys previously managed, printed over a billion shares followed by 2 reverse splits. What has Inovio produced in 35 years of existence? Nothing, not even one Phase 3 trial was completed. The dilution just destroyed shareholders as the pps tanked from $50.00 to 50 cents, before the recent 1 for 4 reverse split.
Look at the results, not the spin that scammers feed you.